The estimated Net Worth of John C Heinmiller is at least $759 Tausend dollars as of 7 March 2019. Mr. Heinmiller owns over 1,250 units of Teleflex stock worth over $338,430 and over the last 6 years he sold TFX stock worth over $0. In addition, he makes $420,835 as Independent Director at Teleflex.
John has made over 1 trades of the Teleflex stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 1,250 units of TFX stock worth $356,250 on 7 March 2019.
The largest trade he's ever made was buying 1,250 units of Teleflex stock on 7 March 2019 worth over $356,250. On average, John trades about 156 units every 0 days since 2019. As of 7 March 2019 he still owns at least 1,384 units of Teleflex stock.
You can see the complete history of Mr. Heinmiller stock trades at the bottom of the page.
John C. Heinmiller serves as Independent Director of the Company. Mr. Heinmiller was Executive Vice President of St. Jude Medical, Inc. (“St. Jude Medical”), a global medical device company. During his 19-year career with St. Jude Medical, Mr. Heinmiller served in various executive and senior level positions, including Executive Vice President from August 2012 to January 2017; Executive Vice President and Chief Financial Officer from May 2004 to August 2012; Vice President, Finance and Chief Financial Officer from September 1998 to May 2004; and Vice President of Corporate Business Development from May 1998 to September 1998. Prior to joining St. Jude Medical, Mr. Heinmiller held senior management positions with and was a member of the board of directors of Daig Corporation, a medical device company, and LifeCore Biomedical, a medical technology company.
As the Independent Director of Teleflex, the total compensation of John Heinmiller at Teleflex is $420,835. There are 9 executives at Teleflex getting paid more, with Liam Kelly having the highest compensation of $6,782,760.
John Heinmiller is 65, he's been the Independent Director of Teleflex since 2019. There are 3 older and 14 younger executives at Teleflex. The oldest executive at Teleflex Incorporated is George Babich, 68, who is the Lead Independent Director.
John's mailing address filed with the SEC is 1 St Jude Medical Dr, St Paul, MN 55117, USA.
Over the last 21 years, insiders at Teleflex have traded over $16,880,558 worth of Teleflex stock and bought 4,250 units worth $1,104,860 . The most active insiders traders include Gretchen R Haggerty, W Kim Foster und Benson Smith. On average, Teleflex executives and independent directors trade stock every 22 days with the average trade being worth of $1,065,906. The most recent stock trade was executed by Stuart A Randle on 16 August 2024, trading 2,674 units of TFX stock currently worth $323,554.
teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. headquartered in wayne, pa, teleflex employs approximately 12,000 people worldwide and serves healthcare providers in more than 150 countries.
Teleflex executives and other stock owners filed with the SEC include: